Cloning, Stem Cells, and Beyond

By Cohen, Eric; Kristol, William | The Human Life Review, Summer 2001 | Go to article overview
Save to active project

Cloning, Stem Cells, and Beyond


Cohen, Eric, Kristol, William, The Human Life Review


Last week's vote in the House to ban human cloning is something to celebrate. It may even be something momentous. The House passed, by 265 to 162, a bill sponsored by representative Dave Weldon of Florida that would ban the creation of all human clones. It rejected an alternative sponsored by Pennsylvania representative James Greenwood, and backed by the biotech lobby, that would have allowed the creation of cloned human embryos to be used for medical research and then destroyed.

The Greenwood forces had corporate money and much of enlightened opinion behind them. They over-promised, misled, and demagogued, claiming, for example, that cloned-embryo research could one day "end human suffering," that cloned embryos "are not really embryos at all," and that a vote against such research is a "sentence of death for millions of Americans."

But the majority of the House-a larger majority than expected-refused to listen. They chose instead to halt (or try to halt) what Charles Krauthammer has described as "the most ghoulish and dangerous enterprise in modern scientific history: the creation of nascent cloned human life for the sole purpose of its exploitation and destruction." They defied the wishes of the medical research establishment, the biotech industry, and the health-at-any-cost humanitarians. They drew a bright moral line, which even the most well-meaning scientists would not be permitted to cross.

Whether this line will hold in the long run-and even whether the Senate will pass a similar cloning ban-is an open question. For while last week's House vote struck a blow against a Brave New World, it represents only the first public engagement in what will surely be a prolonged struggle, not just over cloning and stem cells, but over whether and how to regulate, control, and shape the genetic revolution that is upon us.

One lesson of last week's debate is that everyone claims to be horrified by the prospect of live human clones. Even the Greenwood bill ostensibly banned reproductive cloning. This suggests a broad willingness to accept some moral limitations, enforced in law, on scientific "progress." It suggests we still believe there are great and obvious evils that no amount of utilitarian or libertarian reasoning can justify, and which we must regulate, forbid, and criminalize in the public interest.

But we have also learned something else: Over one-third of the House of Representatives believes that corporations and researchers-like Advanced Cell Technology in Worcester, Massachusetts, which has already begun a research cloning project-should be left alone in the hope that cloned-embryo farms will one day prove a useful source of embryonic stem cells. And we know that majorities in both the House and Senate support federal funding for embryonic stem cell research, at least when the embryos are "leftovers" from in vitro fertilization clinics. Nor have we seen any urgent effort to ban the creation of embryos by private organizations-like the Jones Institute in Norfolk, Virginia, discussed in these pages two weeks ago-that pay women to help produce embryos for research and destruction.

And despite all the publicity surrounding the president's pending decision on embryonic stem cells, it is worth noting that his decision will be a limited one, touching only on the question of federal funding of research on stem cell lines derived from spare in vitro embryos. Even if the president maintains the current ban on funding, Congress will challenge him with a bill of its own-and may well try to broaden the permissible uses of federal funds. And whatever the president and Congress decide about federal funding, this research will presumably proceed apace in the private sector-and not just on leftover in vitro embryos but on embryos created solely for research and destruction.

All of this means that last week's cloning debate in the House and President Bush's imminent stem cell decision are just the tip of the iceberg.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited article

Cloning, Stem Cells, and Beyond
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?